Profil
Currently, Anna Mari Scheiffele is Director at Novartis Pharmaceuticals UK Ltd. since 2018 and Chief Product Officer & Executive Vice President at Ipsen SA starting in 2025.
Formerly, Dr. Scheiffele was a Partner at McKinsey & Co., Inc. Education includes a doctorate from Harvard Medical School.
Postes actifs de Anna Scheiffele
| Sociétés | Poste | Début |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 01/11/2021 |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Directeur/Membre du Conseil | 09/05/2018 |
Anciens postes connus de Anna Scheiffele
| Sociétés | Poste | Fin |
|---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Formation de Anna Scheiffele
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















